Peña-Espinoza Barbara Itzel, Granados-Silvestre María de Los Ángeles, Sánchez-Pozos Katy, Ortiz-López María Guadalupe, Menjivar Marta
Laboratorio de Genómica de la Diabetes, Facultad de Química en la Unidad Académica de Ciencia y Tecnología de la UNAM, Yucatán, Mérida, Yucatán, México.
Laboratorio de diabetes, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.
Endocrinol Diabetes Nutr. 2017 Aug-Sep;64(7):369-376. doi: 10.1016/j.endinu.2017.04.004. Epub 2017 Jun 3.
Early identification of children with metabolic syndrome (MS) is essential to decrease the risk of developing diabetes and cardiovascular disease in adulthood. Detection of MS is however challenging because of the different definitions for diagnosis; as a result, preventive actions are not taken in some children at risk. The study objective was therefore to compare prevalence of MS in children according to the IDF, NCEP-ATP-III, Cook, de Ferranti and Weiss definitions, considering insulin resistance (IR) markers such as HOMA-IR and/or metabolic index (MI).
A total of 508 Mexican children (aged 9 to 13 years) from seven schools were enrolled in a cross-sectional study. Somatometric, biochemical, and hormonal measurements were evaluated.
Frequency of MS was 2.4-45.9% depending on the definition used. Frequency of IR in children not diagnosed with MS was 12.4-25.2% using HOMA-IR and 4.0-16.3% using MI. When HOMA-IR or MI was included in each of the definitions, frequency of MS was 8.5-50.2% and 7.7-46.9% respectively. The kappa value including HOMA-IR and/or MI was greater than 0.8.
This study demonstrated the poor effectiveness of the current criteria used to diagnose MS in Mexican children, as shown by the variability in the definitions and by the presence of IR in children who not diagnosed with MS. Inclusion of HOMA-IR and/or MI in definitions of MS (thus increasing agreement between them) decreases the chance of excluding children at risk and allows for MS prevalence between populations.
早期识别患有代谢综合征(MS)的儿童对于降低成年后患糖尿病和心血管疾病的风险至关重要。然而,由于MS的诊断定义不同,其检测具有挑战性;因此,一些有风险的儿童未采取预防措施。因此,本研究的目的是根据国际糖尿病联盟(IDF)、美国国家胆固醇教育计划成人治疗组第三次报告(NCEP-ATP-III)、库克(Cook)、德费兰蒂(de Ferranti)和魏斯(Weiss)的定义,考虑胰岛素抵抗(IR)标志物如稳态模型评估胰岛素抵抗(HOMA-IR)和/或代谢指数(MI),比较儿童MS的患病率。
从七所学校招募了总共508名墨西哥儿童(9至13岁)进行横断面研究。对人体测量学、生化和激素测量进行了评估。
根据所使用的定义,MS的频率为2.4%-45.9%。未被诊断为MS的儿童中,使用HOMA-IR时IR的频率为12.4%-25.2%,使用MI时为4.0%-16.3%。当将HOMA-IR或MI纳入每个定义时,MS的频率分别为8.5%-50.2%和7.7%-46.9%。包括HOMA-IR和/或MI的kappa值大于0.8。
本研究表明,目前用于诊断墨西哥儿童MS的标准效果不佳,定义的变异性以及未被诊断为MS的儿童中存在IR均表明了这一点。将HOMA-IR和/或MI纳入MS的定义(从而增加它们之间的一致性)可降低排除有风险儿童的可能性,并有助于比较不同人群之间的MS患病率。